ClinicalTrials.Veeva

Menu

Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes

P

Pediatrix

Status

Completed

Conditions

BPD - Bronchopulmonary Dysplasia

Treatments

Other: No interventions or procedures

Study type

Observational

Funder types

Other

Identifiers

NCT04971694
830900795

Details and patient eligibility

About

Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).

Full description

The investigators propose performing a retrospective analysis of the current respiratory management methods to potentially find a correlation between the number of steroid doses administered, the timing of initiation of steroid therapy and the effect on premature infants at risk for developing BPD. The investigators are also going to explore the number and timing of diuretic medications and average fluid intake.

Enrollment

175 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants born at <30 weeks and/or <1500g
  • Admitted to BUMCP between January 1, 2019 and December 31, 2020

Exclusion criteria

  • Infants that do not survive to 36 weeks CGA, when the determination of BPD is made
  • Infants that are transferred to another hospital prior to 36 weeks CGA
  • Out born infants
  • Infants with life threatening congenital anomalies
  • Investigator discretion as to other factors which might impact the study

Trial design

175 participants in 1 patient group

Inclusion Group
Description:
Infants born at \<30 weeks and/or \<1500g that were admitted to BUMCP between January 1, 2019 and December 31, 2020
Treatment:
Other: No interventions or procedures

Trial contacts and locations

1

Loading...

Central trial contact

Becky Micetic; Christine Wade

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems